XML 19 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Oct. 01, 2022
Oct. 02, 2021
Oct. 01, 2022
Oct. 02, 2021
Jan. 01, 2022
Cash flows from operating activities:          
Net income (loss)     $ (35,671) $ 72,176  
Adjustments to reconcile net income (loss) to net cash provided by operating activities:          
Depreciation and amortization     61,065 61,257  
Amortization of operating lease right-of-use assets $ 4,366 $ 3,354 12,539 9,901  
Amortization of deferred debt financing costs and bond discount/premium     3,530 3,444  
Deferred income taxes     (27,415) 14,894  
Impairment of assets held for sale 103,625   103,625    
Gain on sales of assets     (7,094)    
Share-based compensation expense     2,984 3,228  
Changes in assets and liabilities, net of effects of businesses acquired:          
Trade accounts receivable     (31,876) (46,702)  
Inventories     (206,704) (177,785)  
Prepaid expenses and other current assets     (8,926) (1,559)  
Income tax receivable/payable, net     (10,154) 8,705  
Other assets     (1,379) (746)  
Trade accounts payable     101,108 83,530  
Accrued expenses     (5,856) (32,921)  
Other liabilities     1,816 15,364  
Net cash (used in) provided by operating activities     (48,408) 12,786  
Cash flows from investing activities:          
Capital expenditures     (17,421) (31,679)  
Proceeds from sales of assets     10,430 632  
Payments for acquisition of businesses, net of cash acquired     (27,290)    
Net cash used in investing activities     (34,281) (31,047)  
Cash flows from financing activities:          
Repayments of borrowings under revolving credit facility     (182,500) (85,000)  
Borrowings under revolving credit facility     330,000 155,000  
Proceeds from issuance of common stock, net     65,233 2,112  
Dividends paid     (99,312) (92,069)  
Proceeds from exercise of stock options     60 14,811  
Payments of tax withholding on behalf of employees for net share settlement of share-based compensation     (4,041) (1,708)  
Payments of debt financing costs       (276)  
Net cash provided by (used in) financing activities     109,440 (7,130)  
Effect of exchange rate fluctuations on cash and cash equivalents     (377) 271  
Net increase (decrease) in cash and cash equivalents     26,374 (25,120)  
Cash and cash equivalents at beginning of period     33,690 52,182 $ 52,182
Cash and cash equivalents at end of period 60,064 27,062 60,064 27,062 $ 33,690
Supplemental disclosures of cash flow information:          
Cash interest payments     79,891 95,771  
Cash income tax payments     22,908 2,155  
Non-cash investing and financing transactions:          
Dividends declared and not yet paid $ 34,043 $ 30,826 34,043 30,826  
Accruals related to purchases of property, plant and equipment     1,197 1,803  
Right-of-use assets obtained in exchange for new operating lease liabilities     $ 2,851 $ 32,202